Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2479428 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD244 Molecule, Natural Killer Cell Receptor 2B4 (CD244) antibody (Alexa Fluor 488)
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- 2B4-69
- Vial size
- 100 tests
Submitted references Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse.
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.
Bengsch B, Martin B, Thimme R
Journal of hepatology 2014 Dec;61(6):1212-9
Journal of hepatology 2014 Dec;61(6):1212-9
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
Raziorrouh B, Schraut W, Gerlach T, Nowack D, Grüner NH, Ulsenheimer A, Zachoval R, Wächtler M, Spannagl M, Haas J, Diepolder HM, Jung MC
Hepatology (Baltimore, Md.) 2010 Dec;52(6):1934-47
Hepatology (Baltimore, Md.) 2010 Dec;52(6):1934-47
CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse.
Romero X, Zapater N, Calvo M, Kalko SG, de la Fuente MA, Tovar V, Ockeloen C, Pizcueta P, Engel P
Journal of immunology (Baltimore, Md. : 1950) 2005 Jun 1;174(11):7033-42
Journal of immunology (Baltimore, Md. : 1950) 2005 Jun 1;174(11):7033-42
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.
Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L
British journal of haematology 1990 Mar;74(3):277-81
British journal of haematology 1990 Mar;74(3):277-81
No comments: Submit comment
No validations: Submit validation data